SAN FRANCISCO, CA / ACCESSWIRE / June 11, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
SALT LAKE CITY, UT / ACCESSWIRE / June 10, 2019 / ProLung, Inc. ("ProLung" or the "Company"), which is focused...
TORONTO, ON / ACCESSWIRE / June 10, 2019 / GeneNews Limited (TSX: GEN), a life sciences company specializing in blood-based...
Madrid hospital finds CompuFlo a reliable technique for blood patch procedures European School of Obstetric Anesthesia reports CompuFlo improves trainee...
Favorable risk/benefit analysis outlined in report to FDA ALACHUA, FL / ACCESSWIRE / June 10, 2019 / CTD Holdings, Inc....
Dr. Stetson, Who is Medical Director of Diamond Vision, is Again Seeing Patients and Performing Surgery at the Paramus Office...
Mr. Appell brings over twenty years of experience in building high volume transactional-related platforms to deliver large revenue streams SANTA...
Parnell Delivers 9% Revenue Growth in Quarter 1 of 2019 Compared to 2018, and Confirms Provisional 2019 Guidance for a...
LOS ANGELES, CA / ACCESSWIRE / June 7, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year...
OAKVILLE, ON / ACCESSWIRE / June 7, 2019 / Health Partners International of Canada (HPIC) will be hosting a delegation...
WESTLAKE VILLAGE, CA / ACCESSWIRE / June 6, 2019 / Arcutis, Inc., a privately held immuno-dermatology drug development company addressing...
HONG KONG, CHINA / ACCESSWIRE / June 6, 2019 / Young, elderly, man, woman, dumb, wise, rich or poor no...
ATLANTA, GA / ACCESSWIRE / June 5, 2019 / Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of integrated solutions, technology-enabled...
Adial Reaffirms on Track to Commence Phase 3 Trial in Q3 2019 CHARLOTTESVILLE, VA / ACCESSWIRE / June 6, 2019...
DECN Awaits Major Proposition On Or About June 10, Notifies Two Entities That Their Earlier Propositions Do Not Meet Requirements,...
Shares of Common Stock to Begin Trading on Split-Adjusted Basis on June 7, 2019 SAN FRANCISCO, CA / ACCESSWIRE /...
ROGGWIL, SWITZERLAND / ACCESSWIRE / June 5, 2019 / Resaphene Suisse AG, ISIN CH0367465439, WKN A2JG91, has been notified of...
Report highlights input from 20 leading healthcare CISOs who offer their perspective on evolving cyberattacks, ransomware and the biggest concerns...
SAN FRANCISCO, CA / ACCESSWIRE / June 5, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
Phase 2 BRACELET-1 study to evaluate Oncolytics' systemically delivered oncolytic virus, pelareorep, in combination with paclitaxel and anti-PD-L1 antibody avelumab...